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Abstract 
Infection of Epstein Barr virus (EBV) to its host cells is initiated by the attachment of the glycoprotein gp 350/220 to the CR2 
molecule. We used the sensitivity at the polar environment of the fluorescent probe Laurdan to study the membrane viscosity distribution 
from single leaving cells on two lymphoid cell lines Raji and Akata. Lipid analysis on both cells line demonstrated a lower cholesterol to 
phospholipid molar ratio on Akata than Raji cells. Cell fluidity analysis by Laurdan generalized emission polarization (GP) or by DPH 
polarization, indicated that membrane viscosity of Akata was lower than Raji cells. This difference was correlated to the increased 
susceptibility of Akata cells in expressing EBV early antigens (EA) after EBV superinfection. 
Kqwords: Epstein Barr virus; Membrane fluidity; Laurdan 
1. Introduction 
Epstein Barr virus (EBV) is a human herpes virus 
etiologically linked to infectious mononucleosis and closely 
associated with at least two human malignancies, Burkitt’s 
lymphoma and nasopharyngeal carcinoma [ 1,2]. EBV can 
infect human B lymphocytes in vitro; cells became immor- 
talized and the viral genome persists in infected cells in a 
latent state [3]. We have shown that calcium modulation 
activates the viral genome in vitro, leading to induction of 
viral antigen expression and that this event is mediated by 
activation of cellular protein kinase C (PKC) [4-61. Super- 
infection of latently infected cells can also induce within 
few hours early antigen (EA) production [7]. The EBV 
receptor, the CR2 molecule, is a 145 kDa glycoprotein also 
known as the receptor for the C3d fragment of the comple- 
ment [8,9]. The major EBV envelope glycoprotein gp 
3.50/220 binds to CR2 [lo,1 11, virus fusion is then medi- 
Abbreviations: gp, glycoprotein; GP, generalized polarization; CR2, 
complement receptor type 2; EA, early antigens; DPH, diphenylexathriene; 
R18, octadecyl rhodamine B chloride; bisindolylmaleimide, 2-(l-(3-di- 
methylaminopropyl)-1H-indo1-3-y1)-3-(1H-indol-3-yl)-ma1eimide; PKC, 
protein kinase C; PS, phosphatidylserine. 
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ated by a third viral glycoprotein, the gp 85 protein, that 
allowed the virus to enters cells either by direct fusion or 
receptor mediated endocytosis, depending on the cell type 
[ 12,131. For virus cell membrane fusion to occur, the 
apposing membrane bilayers have to undergoes structural 
changes leading to lipid rearrangements and deformations. 
A numbers of lipids including cholesterol and its hy- 
drophilic ester cholesterol hemisuccinate, can modulate 
membrane fusion through changes in membrane fluidity 
[ 151. It has recently been suggested [ 161 that the inability 
of EBV to fuse with some CR2 positive cell line could be 
related to specific lipid composition of the plasma mem- 
brane. To better understand the role of cell membrane 
composition in the first steps of EBV entry into lymphoid 
cells, we used the fluorescent membrane probes Laurdan 
and DPH. Laurdan is located at the hydrophilic/hydro- 
phobic interface of the membrane bilayer [ 17,181 with the 
lauric acid tail anchored in the phospholipid acyl chain 
region, and is known to be sensitive to the polarity of the 
environment, displaying a large red shift of the emission in 
polar solvent with respect to non polar solvents [19]. 
Parasassi [20] demonstrated that is possible by Laurdan 
emission spectroscopy to quantitate both the relative 
amount of gel (blue emission 435 nm> and liquid crys- 
talline phases (red emission 490 nm). They also suggested 
that the quantitation of the phases can be obtained using 
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steady-state generalized polarization (GP). They define 
‘generalized polarization’ to be 
GP = hue - L/~~,ue + Ired (‘1 
Fluorescence microscopy, to study membrane fluidity 
by fluorescence polarization measurements, has not been 
used so far due to technical and physical problems related 
to the use of polarizers. We successfully used Laurdan to 
monitor membrane fluidity in fluorescence microscopy 
thanks to the sensitivity of this probe to the polarity of 
microenvironment. Fluorescence microscopy, with respect 
to steady state measurements, has less variation due to cell 
population heterogeneity. Laurdan is a membrane probe 
that can be utilized to study membrane fluidity by fluores- 
cence emission instead of fluorescence emission polariza- 
tion, thus enabling us to study membrane fluidity by 
fluorescence microscopy on single cells to better define the 
early stages of EBV replication. In the present work we 
correlate membrane fluidity and disruption of EBV latency 
in Akata cells, we also attempted to quantify single cell 
membrane fluidity, using the fluorophore Laurdan. 
2. Materials and methods 
2. I. Materials 
Octadecylrhodamine B chloride (R18) and 6- 
dodecanoyl-2-dimethylaminonaphtalene (Laurdan) were 
obtained from Molecular Probes (Junction City, OR), Tri- 
ton X- 100 from Aldrich, TPA from Sigma, [-y-j’ PIATP 
(3000 Ci/mmol) from Amersham, bisindolylmaleimide 
from Calbiochem. 
2.2. Cell cultures 
Raji and Akata cells were grown in RPM1 (Gibco 
Laboratories, UK) supplemented with 10% Fetal Calf 
Serum (Gibco Laboratories, UK) and antibiotics (110 
III/ml of penicillin and 100 pg/ml of streptomycin) at 
37°C 5% CO,. All this cells line are EBV genome-posi- 
tive which express CR2. 
2.3. Virus production 
P3HRl virus was harvested from the spent supematant 
of P3HRl cells grown for 14 days at 37”C, clarified by 
centrifugation (2000 X g, 15 min). The virus was pelleted 
at 20000 X g for 90 min. Pellets were suspended in l/250 
of the original volume and filtered through a 0.45 pm pore 
filter. 
2.4. Lipid phosphate analysis 
Lipid phosphate analysis was performed using the 
molybdate-ascorbate method as previously reported [21]. 
2.5. Cholesterol analysis 
Cholesterol content of the extracted lipids was deter- 
mined using the calorimetric method of Zlatkis et al. [22] 
An aliquot of the chloroform solution containing cellular 
lipids was evaporated under nitrogen stream. Than the 
dried lipids were acidified with acetic acid and vortexed 
vigorously. Two ml of diluted color reagent (2.5 g FeCl, 
6H20/100 ml of 85% orthophosphoric acid diluted 1: 12.5 
with concentrated sulfuric acid) was added to the tubes and 
the content were gently mixed. Than absorbance was read 
at 550 nm. 
2.6. Cholesterol enrichment 
Cholesterol enrichment of Raji and Akata cells mem- 
brane has been performed using PVP complexed with BSA 
described by Shinitzky et al. [23] and modified by Pate1 et 
al. [24]. The complex was prepared as follows: 3.5% PVP 
in PBS was dialyzed overnight and cholesterol was added 
to provide a final concentration of 260 nmol. 
2.7. In citro phosphorylation 
Raji and Akata cells (5 . 106), native or cholesterol 
enriched, were rinsed with Locke’s solution (154 mM 
NaCl, 5.6 mM KCl, 3.6 mM NaHCO,, 2.3 mM CaCl,, 5.6 
mM glucose, 5 mM Hepes, pH 7.4) containing 1 mM 
MgCl,. Labeling was carried out in 100 ~1 Locke’s 
solution containing 0.4 mM MgC12 and 0.3 mCi/ml 
[“‘Plorthophosphate for 45 min at room temperature on a 
rocker. The PKC inhibitor Bisindolylmaleimide (0.5 PM) 
were added to the cultures 30 min prior to stimulation with 
TPA/Butirrate. At various time points cells were briefly 
rinsed with (2 X 0.5 ml) Locke’s solution and collected 
with (3 X 0.25 ml) chilled cell lysis buffer (1 mM MgCl,, 
0.5 mM EGTA, 0.5 mM dithiothreitol (DTT), 2% pyro- 
phosphate, 5 mM Tris-Cl, pH 7.4). Ice-cold trichloroacetic 
acid (TCA) was quickly added to the lysates (20% (w/v) 
final) and after incubation on ice for 30 min, precipitates 
were collected by centrifugation. Pellets were resuspended 
in 50 ~1 of SDS sample buffer (9 M urea, 0.14 M 
P-mercaptoethanol, 0.04 M DTT, 2% SDS, 0.075 M Tris- 
Cl, pH 8.0) and boiled for 5 min. (25) 
2.8. Electrophoresis 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
was carried out according to Laemmli [26]. Equal volumes 
of sample (20 pi/well) were loaded. Two-dimensional gel 
electrophoresis was carried out in according to [25]. Equal 
volumes of samples (11 pi/well) were loaded. The first 
dimensional non equilibrium isoelectric focusing gels (1.8 
X 75 mm) containing a 3% total carrier ampholytes mix- 
ture composed of 75% pH 3.5-9.5, 25% pH 5.0-8.0, 9 M 
urea, 0.5% Nonidet P-40, 1.6% 3-(3-cholamidopropyl)di- 
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methylammonio)- 1 -propanesulfonate (Chaps), 5% acryl- 
amide were run for 1500 Vh; the second dimension was 
carried out on 6-14% SDS polyacrylamide gradient gel. 
Incorporation of 32P label was revealed by autoradiog- 
raphy and, in two-dimensional gels, quantitated with a 
Phosphorimages Densitometer (Molecular Dynamics). 
2.9. Protein kinase C assay 
Cytosol and membrane fractions were adsorbed in a 1.5 
ml microcentrifuge tube to a 0.2 ml of DEAE-Sepharose 
fast flow equilibrated in buffer A (20 ml Hepes, pH 
7.5-10 mM P-mercaptoethanol-0.5 mM EDTA-0.5 mM 
EDTA), washed three times with buffer A and eluted with 
0.2 M NaCl in buffer A. The 0.2 M NaCl eluate were 
incubated in a 50 ~1 reaction mixture containing 20 mM 
Tris-HCl (pH 7.5) 10 mm MgCl,, 40 pg of histone H,, 
100 pg/ml of PS, 500 PM CaCl, or 200 PM EGTA in 
place of CaCl, and PS. Assays were carried out as previ- 
ously reported [ 141. 
2. IO. Virus fusion assay 
P3HRl virus was labeled with R18 as described previ- 
ously [27]. R18-P3HRl was preincubated with Raji and 
Akata cells at 4°C for 30 min to form virus-cells complex 
and unbound virus was removed by centrifugation in a 
12 X 75-mn polystyrene tube at 330 X g. The pellet con- 
taining the complex was resuspended in phosphate buffer 
and kept on ice. 50 ~1 of the complex were added to 2 ml 
of buffer prewarmed at 37°C. Percentage of fluorescence 
dequenching (%FDQ) was calculated according to Eq. 2: 
%FDQ = (F - F,/F, - F,,) X 100 (2) 
were F, and F are the fluorescence intensity at time 0 and 
at given point, F, is the fluorescence after Triton addition. 
2.1 I. Laurdan labeling of cell membrane 
Laurdan labeling procedure is according to Parasassi et 
al. [28]. 1 * lo6 of each cells type were washed three times 
with PBS, then resuspended in 2.5 ml of PBS. 0.5 ~1 of a 
2.5 mM solution of Laurdan in DMSO were added to cell 
suspension under mild magnetic stirring. Incubation were 
carried out in the dark for 20 min. Cells were than pelleted 
and washed with PBS, resuspended in 2.5 ml of PBS, 
equilibrated for 5 min in the fluorescence microscope at 
20°C than measured. These labeling conditions were de- 
termined after dilution experiments, where the GP value 
was reported as a function of the ratio (lo6 cell per 
ml/(mol Laurdan) (C/L). Since Laurdan can diffuse from 
the plasma membrane to intracellular membranes each set 
of cells (50 to 70 cells) were analyzed within 10 min. 
Within this time frame only the plasma membrane appears 
fluorescent when laurdan is excited at 360 nm under the 
epifluorescence microscope. Each experiment repeated up 
to 10 times. 
2.12. Generalized polarization measurements 
Single cell Laurdan emission fluorescence were ob- 
tained using an Olympus BH2 epifluorescence microscope 
equipped with a photo tube and a special software (ISS 
Inc., Champaigne, IL). The microscope was equipped with 
photon counting electronics PXOl (ISS). the Excitation 
(360 nm) and emission (435/490) filters (Corning) band- 
pass were 5 nm. The emission were corrected for the lamp 
intensity variation. GP values using 360 nm as excitation 
wavelength were obtained from Eq. 2: 
GP = Ia35 - 490/~43, + 49” 
where Id35 and I,,, are the intensities at each wavelength. 
In some experiment Laurdan excitation and emission spec- 
tra were recorded using a Perkin-Elmer 650-40 spectro- 
fluorometer using a xenon lamp as the light source and the 
accompanying software (ISS, Urbana Champaign, IL). 
2.13. Fluorescence polarization measurements 
1,6-Diphenyl-1,3,5-hexatriene (DPH) (Sigma) and 1,2- 
trimethylamino-6-phenylexa-1,3,5-triene (TMA-DPH) 
(Sigma), a cationic analog of DPH, were used for monitor- 
ing the fluidity in the hydrocarbon core and the exofacial 
leaflet of the plasma membrane, respectively [24]. Label- 
ing of intact cells was performed by adding 2 ~1 of 1 mM 
DPH in tetrahydrofuran or TMA-DPH in dimethylsulf- 
oxide to 40 pg of protein/ml. Than incubated in the dark 
at 4°C for 60 min. Fluorescence polarization was measured 
using a Perkin Elmer 650-40 spectrofluorometer. The de- 
gree of fluorescence polarization P, defined in the follow- 
ing equation was directly recorded. 
P = I, - 1,/I, + I, 
I, and I, are the emission intensities when the polariz- 
ers are oriented vertically and horizontally, respectively. 
2.14. Early Antigens (EA) detection 
After 72 h from cell superinfection or induction, cells 
were analyzed for EBV EA production by the indirect 
immunofluorescent test [5]. Cells were first fixed at - 20°C 
in acetone than incubated for 30 min at 37°C with human 
anti EA MoAb. After extensive washing cells were incu- 
bated with a fluoresceinated secondary antibody, than EA 
analysis was carried out using an epifluorescence micro- 
scope and the results expressed as %  EA positive cells. 
2.15. Flow cytometer analysis of CR2 molecule 
Cells from culture were washed in PBS and fixed in 2% 
paraformaldehyde. For indirect immunofluorescence, 50 
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Table 1 
CR2 and EA expression on Raji and Akata cells 
Cells type %CR2 %EA 
Raji 90 7.5 
Akata 20 25 
EA were detected in Raji and Akata cells after EBV superinfection and 
expressed as %EA positive cells by the indirect immunofluorescent assay. 
CR2 were quantitated in control Raji and Akata cells by flow cytometry 
analysis as described under Section 2. 
~1 of cell suspension with approx. lo6 cells were incu- 
bated with 20 ~1 anti-CR2 MoAb for 30 min on ice, then 
washed and resuspended in 50 ~1 of PBS. 4 ~1 of 
fluoresceinated secondary antibody were added and the 
cells incubated at 4°C in the dark for 30 min. Cells were 
resuspended in 200 ,ul PBS and kept on ice until FACS 
analysis. For negative controls the cells were incubated 
only with the secondary antibody. Fluorescence was de- 
tected using a FACScan Flow Cytometer (Becton Dickin- 
son) equipped with air-cooled Argon-ion laser emitting at 
488 nm and single parameter histograms were collected for 
green fluorescence. 
3. Results 
3.1. CR2 and EA expression on Raji and Akata cells 
Akata cells EBV superinfected proved to be more sus- 
ceptible to EA production compared to Raji cells. The 
higher susceptibility of Akata is, to some extent, surprising 
since by FACS analysis of CR2 molecule, those cells are 
less positive than Raji (Table 1). Incubation of RI8 labeled 
EBV with Akata resulted in a higher RI8 fluorescence 
dequenching than found with Raji. The amount of EBV 
bound to both cell lines has been quantified (data not 
shown) by measuring the fluorescence after Triton X-100 
addition, providing a relative measure of the amount of 
virus bound that, for Akata, was 70% less than what found 
for Raji cells. Despite EBV binds to less extent to Akata, 
the virus fuses and penetrate better with this cells than Raji 
(Fig. 1). 
3.2. Lipids and cholesterol profile of Raji and Akata cells 
To determine if the difference in the ability of EBV to 
fuse and induce EA with Akata compared to Raji cells 
might be related to difference in cell membrane lipids, as 
already reported for other cell types [ 161, lipid and choles- 
terol analysis was performed on both cell types. Both cell 
lines contained similar amount of cholesterol expressed per 
mg of cell protein (Table 2). Phospholipids phosphate 
analysis, showed that Akata cells had more phospholipid 
phosphate per mg of protein, resulting in a lower choles- 
terol/phospholipid molar ratio of Akata compared to Raji 
cell membranes. 
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Fig. 1. Effect of cholesterol on the kinetics of EBV entry in Akata and 
Raji cells. 2. IOh/ml cells were incubated with R18EBV for 1 h at 4°C. 
Fusion was then followed for Akata (-1, Akata cholesterol enriched 
( W ), Raji ( * ) and Raji cholesterol enriched (0) using 560 and 590 nm 
as excitation end emission wavelengths, respectively. Data are expressed 
as % of RI8 fluorescence dequenching after Triton X-100 addition. 
3.3. Membrane cholesterol and kinetics of EBVfusion with 
Raji and Akata cells 
To understand, to some more extent, the correlation 
between Akata and Raji cell membrane composition and 
EBV fusion, we attempted to modify cell membrane com- 
position. Incubation of Akata and Raji cells with choles- 
terol-hemisuccinate dramatically changed the 
cholesterol/phospholipid molar ratio of Akata and Raji 
from 0.15 and 0.2 1 to 0.40 cholesterol/phospholipid mo- 
lar ratio. The effect of this increase on Akata and Raji 
membrane cholesterol on their ability to fuse with R18 
labeled EBV is reported in Fig. 1. Cholesterol incorpora- 
tion on Akata and Raji cells membranes resulted in the 
abolishment of the ability of the labeled virus to fuse with 
the cholesterol enriched membrane compared to control 
cells. 
3.4. Luurdan generalized emission polarization of Raji and 
Akata cell membranes 
Measuring fluorescence from single cells by fluores- 
cence microscopy offers the advantage to studying fluores- 
cence distribution compared to the average number ob- 
Table 2 
Cholesterol and phospholipid content 
Source Cholesterol PO4 Cholesterol/ 
(nmol/mg protein) (nmol/mg protein) phospholipids 
(molar ratio) 
Raji 20.6 100 0.21 
Akata 23 156 0.15 
Lipids determination were carried out using total lipid extracts as de- 
scribed under Section 2. 
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0.254 
Raii Akata Akata cholesterol 
Fig. 2. Effect of cholesterol enrichment on Laurdan generalized emission 
polarization of Akata cells. Cells were labeled with Laurdan as described 
under Section 2, than fluorescence were recorded on single leaving cell 
under a fluorescence microscope equipped with a photon counting using 
360 nm as excitation and 435-490 nm for emission wavelengths. Data 
point represent the means of three separate experiments with duplicate 
readings at each temperature. 
tained by steady state measurements under the light of a 
fluorescence spectrophotometer. Additionally, Laurdan is a 
suitable fluorescence probe to detect changes in membrane 
fluidity thanks to the sensitivity of its fluorescent emission 
spectra to the environment. This compared to other mem- 
brane probes, such as DPH, which utilize polarizers to 
detect changes in membrane fluidity, allowed Laurdan to 
be used in all the commonly equipped fluorescence micro- 
scopes. Single cell Laurdan emission GP from Raji and 
Akata generate for the first cell type two GP families 
equally represented, one ranging from GP = 0.35 to 0.45 
the other ranging from 0.35 to 0.25. GP analysis from 
Akata cells identified only one family with GP distributed 
from GP = 0.35 to 0.25. Since higher GP values corre- 
spond to a more rigid membrane, one should expect that 
almost 50% of Raji cell population are characterized by a 
more rigid membrane than Akata (Fig. 2). 
Labeling cholesterol enriched Akata cells with Laurdan 
and analyzing the GP values obtained from each single 
cells, resulted in a shift in each single cell emission GP 
values towards more rigid membranes, generating a family 
of points above ranging from GP = 0.35 to 0.55 (Fig. 2). 
3.5. Membrane fluidity of Akatu cells as measured by DPH 
To investigate in further detail if the varying behavior 
towards EBV fusion of Akata compared to Raji cells could 
arise from difference in cell membrane fluidity, as sug- 
gested by single cell Laurdan emission GP, we analyzed 
membrane fluidity by steady-state DPH fluorescence polar- 
ization spectroscopy. Conversion of polarization values to 
apparent membrane microviscosity values, indicates that 
the membrane of Akata cells are significantly more fluid 
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Fig. 3. Raji and Akata membrane fluidity by DPH fluorescence polariza- 
tion. Effect of temperature on the fluorescence polarization of DPH in 
Akata ( * ), Akata cholesterol enriched (0 ) and Raji (W ). Depicted is an 
Arrhenius plot of DPH polarization between 4 and 40°C. Data point 
represent the means of three separate experiments with duplicate readings 
at each temperature. 
than Raji cells. Addition of cholesterol to reach a choles- 
terol/phospholipid molar ratio of 0.4 is acting as a rigidi- 
fier (Fig. 3). 
3.6. Membrane fluidity of Akata cells as measured by 
TMA-DPH 
The cationic DPH, TMA-DPH analog has spectral char- 
acteristic similar to those of the neutral parent probe DPH. 
The charged substituent in TMA-DPH provide a surface 
anchor improving the partition of the probe mainly in the 
cell plasma membrane [29]. As found in DPH polarization 
experiments, Akata cells plasma membrane demonstrated 
to be in a more fluid situation that Raji and cholesterol 
addition to Akata is acting as a rigidifier (Fig. 4). 
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Fig. 4. Raji and Akata membrane fluidity by TMA-DPH fluorescence 
polarization, Effect of temperature on the fluorescence polarization of 
TMA-DPH in Akata (* 1, Akata cholesterol enriched (0) and Raji (W ). 
Depicted is an Arrhenius plot of DPH polarization between 4 and 40°C. 
Data point represent the means of three separate experiments with 
duplicate readings at each temperature. 
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Table 3 
Effect of membrane cholesterol on R EA expression by EBV superinfec- 
tion on Raji and Akata cells 
Cells type %EA control ‘%A cholesterol 
no EBV EBV no EBV EBV 
Raji 2 1.5 2 2 
Akata 4 25 3 2.5 
After cholesterol enrichment EA were detected as in Table I. 
3.7. Membrane cholesterol and EA e.xpression 
Enrichment of both cell lines in membrane cholesterol, 
modulate the expression of EA after EBV superinfection. 
Incubation with cholesterol hemesuccinate followed by 
EBV induction resulted in an impairment of EA produc- 
tion in both cell lines compared to native cells (Table 3). 
3.8. Membrane cholesterol and PKC acticity 
The role of PKC in the process of EBV entry and EA 
production is well known [14]. We calculated the enzyme 
activity in the membrane and cytosol compartment of Raji 
and Akata cells with or without cholesterol enrichment. 
The calculated enzyme activity has been reported in Table 
4. After induction with the tumor promoter and PKC 
activator TPA, no effect of cholesterol on PKC activity 
was detected in both cell lines. 
3.9. &fleet qf membrane cholesterol on PKC dependent 
protein phosphorylation 
Fig. 5A shows a typical autoradiograph from Akata cell 
lysate (control cells) of the electrophoretic analysis of the 
phosphorylated species resolved in two-dimensional gel. 
Cell membrane enrichment with cholesterol resulted in a 
decrease in the incorporation of 32P in some phosphopro- 
tein (Fig. 5C), those phosphoproteins are specifically phos- 
phorylated by PKC as reported in Fig. 5B and D where the 
phosphorylation was carried out in presence of protein 
kinase C activator TPA or in the presence of the protein 
Table 4 
PKC activity in cytosol and particulate fractions of Raji and Akata cells 
cholesterol enriched 
Treatment PKC activity (pmol/min/mg protein) 
cytosol particulate 
Raji control 364k12” 400+ 19 
Raji cholesterol 390*11 395+21 
Akata control 402+ IO 380 f 20 
Akata cholesterol 400+ 10 395+12 
After cells lysis assay were carried out with the 0.2 M NaCl fraction 
elated from DEAE-Sepharose column as described under Section 2. 
’ meanfS.D. 
Fig. 5. Effect of membrane cholesterol on PKC dependent protein 
phosphorylation. Control (A), TPA induced (B), cholesterol enriched and 
TPA induced (C) and bisindolylmaleimide treated and TPA induced (D) 
Akata cells preincubated with “P. Cells homogenate were separated by 
charge in the first dimension and in SDS PAGE in the second dimension. 
Autoradiograph of the gel shows labelled spots (arrow) corresponding to 
proteins specifically phosphorylated by PKC. 
kinase C inhibitor Bisindolylmaleimide. The same results 
were obtained when Raji cells were used instead of Akata. 
4. Discussion 
Membrane fusion is a complex phenomenon involving a 
wide range of biochemical and biophysical interaction [30]. 
Factors which govern membrane-membrane interaction 
such as the role of lipid structure, head group, shape, 
hydration have been studied deep inside [31,32]. En- 
veloped animal viruses infect cells injecting their nucleo- 
capsid into the host cell. The key to this strategy is 
membrane fusion, either at the plasma membrane or within 
the endocytic vesicles [33]. The fusogenicity of the en- 
veloped virus to target cell membrane has been studied 
using normal cells and liposomes with different lipid com- 
position [34-361. In these studies the hypothesis that the 
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lipid moiety is-important in virus receptor recognition and 
fusion is evident, although little is known about the mecha- 
nism by which lipid can regulate virus fusion. Cholesterol 
seems to modulate the fusion process of several viruses. 
For example binding and fusion of Semliki Forest virus 
[33] and Sendai virus 1371, require cholesterol in the target 
membrane. Pate1 [36] suggested that cholesterol can be of 
same importance in regulating EBV fusion. The mecha- 
nism leading to EBV fusion with its target membrane is a 
process that despite its complexity has been described at 
molecular level [ 12,131. Immediately after binding of the 
viral gp 350/220 to the CR2 molecule, fusion is then 
induced by a third viral protein the gp 85. 
EBV fusion with cells containing the EBV genome 
latently expressed (superinfection) results in the induction 
of the latent viral DNA. In this event PKC plays a central 
role, since phosphorylation of nuclear proteins is needed to 
trigger EBV replication [ 141. 
Indirect immunofluorescence using anti CR2 mono- 
clonal antibodies (OKB-7), specific for a protein sequence 
near the EBV binding domain, showed Akata cells are less 
positive than Raji. This is quite intriguing since Akata cells 
are known to be more susceptible to EBV infection, as also 
reported in the fusion kinetics with R18 label EBV and EA 
production. Since enrichment of Akata cell membranes 
with cholesterol succinate drastically reduces both fusion 
and EA induction, it is possible to argue that modification 
of some properties of the plasma membrane due to choles- 
terol can interfere with EBV infection. 
The relevance of cholesterol for structural and dynamic 
properties of the majority of cell membrane in eucaryotic 
cells is well recognized [28]. The influence of cholesterol 
on the properties of phospholipid bilayers at a molecular 
level has been ruled out using several spectroscopic tech- 
nique. Membrane fluidity is modified by cholesterol induc- 
ing to a more disordered gel phase while the liquid crys- 
talline is ordered [38]. 
Single cell Laurdan emission generalized polarization 
identified on Raji two populations typical of fluid and rigid 
membrane respectively. When the same experiment was 
repeated on Akata cells, Laurdan emission generalized 
polarization generated a single population in the GP range 
from 0.35 to 0.25 typical of fluid membranes. Incubation 
of Akata cells with cholesterol succinate shifted the GP 
values of each single cells towards values corresponding to 
more rigid structures. Since this increase in Laurdan GP 
can be interpreted as a decrease in membrane fluidity 
(rigidification), it is possible to argue that cholesterol is 
rigidifies Akata plasma membranes. We also attempted to 
quantify membrane viscosity using a fluorophore different 
from Laurdan: DPH and TMA-DPH. Such probes monitor 
membrane fluidity through their sensitivity to the polarized 
light, have high extinction coefficients and are not fluores- 
cent in water. Two probes were used because the ionic 
properties of TMA-DPH allow for it to report on the 
motional characteristic of the exofacial leaflet of the plasma 
membrane. Polarization values using DPH and TMA-DPH 
suggested significantly greater hindrance of the probes 
mobility in Raji and in cholesterol enriched Akata at all 
temperature measured than showed by control Akata cells. 
This is consistent with the data obtained by Laurdan 
emission GP and is in accordance with the greater choles- 
terol/phospholipid molar ratio found in Raji as compared 
to Akata. 
On the other end looking at %  EA positive Akata cells 
and GP values from single native and cholesterol enriched 
Akata cells, it can be withdrawn that more rigid is the 
membrane (higher GP values), less inducible is the cell. 
It is surprising that Akata cells which are less positive 
by CR2 indirect immunofluorescence than Raji, are more 
inducible by EBV superinfection. There is a close correla- 
tion between membrane fluidity, EBV fusion and EA 
production. Above a critical GP value characteristic of 
most of the Raji population and cholesterol enriched Akata 
cells, the virus is not able to fuse with its receptor and EA 
induction is blocked. 
In accord with Pate1 [ 161 we also found that the amount 
of virus bound was not affected by the presence of choles- 
terol (data not shown). This implies that fusion and not 
binding is the first in the cascade leading to EA production 
after superinfection. 
The mechanisms leading to disruption of EBV latency 
is initiated by the expression and activation of a nuclear 
protein called ZEBRA (Z Epstein Barr Replicator Activa- 
tor), a phosphoprotein whose function at the nuclear level 
is regulated by phosphorylation. Phosphoprotein analysis 
on native and cholesterol enriched cells demonstrated that 
together with the increase in membrane fluidity there is an 
impairment in the PKC dependent protein phosphorylation 
(Fig. 5). 
Since we demonstrated previously [14] that as a conse- 
quence of EBV binding there is PKC translocation and 
increase in membrane protein phosphorylation, it seems 
reasonable to conclude that the failure for EBV to trigger 
EA production in superinfected cholesterol enriched Akata 
cells. can be related to an impairment in the phosphoryla- 
tion of nuclear protein important for the EBV genome 
activation. 
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